These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 66298)

  • 21. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
    Lüthke K; Conrad K; Frank KH
    Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of anti-double stranded DNA idiotype in mixed connective tissue disease and progressive systemic sclerosis.
    Kubota T; Kanai Y
    Bull Tokyo Med Dent Univ; 1989 Jun; 36(2):13-8. PubMed ID: 2789110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinuclear antibodies in Thai patients with connective tissue diseases.
    Panicheewa S; Verasertniyom O; Chitrabamrung S; Vanichapuntu M; Vatanasuk M
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):47-52. PubMed ID: 3304322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides.
    Alarcón-Segovia D; Fishbein E; Estrada-Parra S; García-Ortigoza E
    Immunology; 1976 Mar; 30(3):413-8. PubMed ID: 1082854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence and clinical significance of antibodies to extractable nuclear antigens.
    Hamburger M; Hodes S; Barland P
    Am J Med Sci; 1977; 273(1):21-8. PubMed ID: 300568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
    Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
    Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
    Parker MD; Kerby GP
    Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mixed connective tissue disease (Sharp's syndrome)].
    Müller W; Rosenthal M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():744-50. PubMed ID: 306173
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 32. Urinary excretion of antinuclear antibodies.
    Meryhew NL; Messner RP; Tan EM
    J Rheumatol; 1983 Dec; 10(6):913-9. PubMed ID: 6363697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Subgroups of connective tissue disease].
    Le Goff P; Youinou P
    Presse Med; 1984 Nov; 13(42):2571-6. PubMed ID: 6239256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of anti-SSB antibodies in patients with rheumatic diseases.
    Tang F; Dong Y; Zhang N
    Chin Med Sci J; 1993 Mar; 8(1):55-8. PubMed ID: 8274726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The "true speckled" antinuclear antibody (ANA) pattern: its tumultuous history.
    Burnham TK; Kleinsmith DM
    Semin Arthritis Rheum; 1983 Nov; 13(2):155-9. PubMed ID: 6369542
    [No Abstract]   [Full Text] [Related]  

  • 37. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
    Zitńan D; Cebecauer L
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospects and problems in the definition and standardization of immunofluorescence. I. Present levels of reproducibility and disease specificity of antinuclear antibody tests.
    Beutner EH; Krasny S; Kumar V; Taylor R; Chorzelski TP
    Ann N Y Acad Sci; 1983; 420():28-54. PubMed ID: 6372596
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera.
    Herrera-Esparza R; Avalos-Diaz E; Barbosa-Cisneros O
    Rev Rhum Engl Ed; 1999 Jun; 66(6):315-8. PubMed ID: 10418059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.